Praxis Precision Medicines, Inc. (PRAX)
334.58
-3.99
(-1.18%)
USD |
NASDAQ |
Sep 11, 16:00
333.00
-1.58
(-0.47%)
After-Hours: 20:00
Praxis Precision Medicines Market Cap : 9.340B for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 9.340B |
| September 10, 2026 | 9.452B |
| September 09, 2026 | 9.640B |
| September 08, 2026 | 9.840B |
| September 04, 2026 | 9.821B |
| September 03, 2026 | 9.915B |
| September 02, 2026 | 9.980B |
| September 01, 2026 | 9.867B |
| August 31, 2026 | 9.779B |
| August 28, 2026 | 9.624B |
| August 27, 2026 | 10.27B |
| August 26, 2026 | 10.53B |
| August 25, 2026 | 10.27B |
| August 24, 2026 | 10.27B |
| August 21, 2026 | 10.49B |
| August 20, 2026 | 10.18B |
| August 19, 2026 | 10.78B |
| August 18, 2026 | 10.32B |
| August 17, 2026 | 10.51B |
| August 14, 2026 | 10.24B |
| August 13, 2026 | 10.29B |
| August 12, 2026 | 10.79B |
| August 11, 2026 | 10.35B |
| August 10, 2026 | 10.24B |
| August 07, 2026 | 10.07B |
| Date | Value |
|---|---|
| August 06, 2026 | 10.33B |
| August 05, 2026 | 8.912B |
| August 04, 2026 | 8.656B |
| August 03, 2026 | 8.511B |
| July 31, 2026 | 8.576B |
| July 30, 2026 | 8.574B |
| July 29, 2026 | 8.108B |
| July 28, 2026 | 8.241B |
| July 27, 2026 | 8.798B |
| July 24, 2026 | 9.063B |
| July 23, 2026 | 8.982B |
| July 22, 2026 | 8.695B |
| July 21, 2026 | 8.856B |
| July 20, 2026 | 8.481B |
| July 17, 2026 | 8.759B |
| July 16, 2026 | 8.586B |
| July 15, 2026 | 8.871B |
| July 14, 2026 | 9.129B |
| July 13, 2026 | 8.763B |
| July 10, 2026 | 9.054B |
| July 09, 2026 | 9.281B |
| July 08, 2026 | 9.277B |
| July 07, 2026 | 9.025B |
| July 06, 2026 | 8.734B |
| July 02, 2026 | 8.874B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Insmed, Inc. | 28.25B |
| Perspective Therapeutics, Inc. | 320.58M |
| Vertex Pharmaceuticals, Inc. | 130.59B |
| AbbVie, Inc. | 454.35B |
| TG Therapeutics, Inc. | 8.249B |
Market Cap Related Metrics
| PEG Ratio | -4.864 |
| Price to Book Value | 6.965 |
| Price | 334.58 |
| Earnings Yield | -3.87% |
| PEGY Ratio | -4.864 |